DK0483961T3 - Specifikke bindemidler - Google Patents

Specifikke bindemidler

Info

Publication number
DK0483961T3
DK0483961T3 DK91308147T DK91308147T DK0483961T3 DK 0483961 T3 DK0483961 T3 DK 0483961T3 DK 91308147 T DK91308147 T DK 91308147T DK 91308147 T DK91308147 T DK 91308147T DK 0483961 T3 DK0483961 T3 DK 0483961T3
Authority
DK
Denmark
Prior art keywords
human antibody
reshaped
specific binders
hmfg1
hmfg
Prior art date
Application number
DK91308147T
Other languages
Danish (da)
English (en)
Inventor
Martine Elisa Verhoeyen
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of DK0483961T3 publication Critical patent/DK0483961T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK91308147T 1990-09-07 1991-09-05 Specifikke bindemidler DK0483961T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909019553A GB9019553D0 (en) 1990-09-07 1990-09-07 Specific binding agents

Publications (1)

Publication Number Publication Date
DK0483961T3 true DK0483961T3 (da) 2003-06-23

Family

ID=10681827

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91308147T DK0483961T3 (da) 1990-09-07 1991-09-05 Specifikke bindemidler

Country Status (18)

Country Link
US (2) US6204366B1 (no)
EP (1) EP0483961B1 (no)
JP (2) JP3514456B2 (no)
KR (1) KR930702526A (no)
AT (1) ATE233279T1 (no)
AU (1) AU653167B2 (no)
BG (1) BG60716B1 (no)
CA (1) CA2090961C (no)
DE (1) DE69133200T2 (no)
DK (1) DK0483961T3 (no)
ES (1) ES2193129T3 (no)
FI (2) FI113873B (no)
GB (1) GB9019553D0 (no)
HU (2) HUT67796A (no)
NO (2) NO314595B1 (no)
RO (1) RO113432B1 (no)
UA (1) UA46691C2 (no)
WO (1) WO1992004380A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
WO1992022653A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. Method for making humanized antibodies
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
CA2103887C (en) * 1991-12-13 2005-08-30 Gary M. Studnicka Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
WO1994011508A2 (en) * 1992-11-13 1994-05-26 Cancer Research Fund Of Contra Costa Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods
US5792852A (en) * 1992-11-16 1998-08-11 Cancer Research Fund Of Contra Costa Polynucleotides encoding modified antibodies with human milk fat globule specificity
DE69332930T2 (de) * 1992-11-16 2004-02-26 Cancer Research Fund Of Contra Costa, Walnut Creek Peptide mit breiter neoplastischer spezifizität
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US5804187A (en) * 1992-11-16 1998-09-08 Cancer Research Fund Of Contra Costa Modified antibodies with human milk fat globule specificity
JPH07203974A (ja) * 1994-01-13 1995-08-08 Tosoh Corp 癌特異的ムチンを認識する抗体の遺伝子断片等
EP0781847A1 (en) * 1995-11-06 1997-07-02 MERCK PATENT GmbH Humanized monoclonal antibody
EP1032420A4 (en) * 1997-11-14 2004-09-15 Euro Celtique Sa IMMUNOGLOBULIN MOLECULES WITH SYNTHETIC VARIABLE REGION AND MODIFIED SPECIFICITY
GB2360771A (en) * 2000-03-28 2001-10-03 Antisoma Res Ltd Compounds for targeting
AU4430701A (en) * 2000-04-03 2001-10-15 Antisoma Research Limited Compounds for targeting
AU2002307064A1 (en) * 2001-04-02 2002-10-15 Purdue Pharma L.P. Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response
GB0200657D0 (en) * 2002-01-12 2002-02-27 Antisoma Plc Cancer treatment
CA2488441C (en) * 2002-06-03 2015-01-27 Genentech, Inc. Synthetic antibody phage libraries
WO2004007687A2 (en) * 2002-07-16 2004-01-22 Stuart Bussell Methods to construct multimeric dna and polymeric protein sequences as direct fusions or with linkers
CA2534055A1 (en) * 2003-08-01 2005-02-10 Genentech, Inc. Antibody cdr polypeptide sequences with restricted diversity
GB0519398D0 (en) * 2005-09-23 2005-11-02 Antisoma Plc Biological materials and uses thereof
EP1957531B1 (en) 2005-11-07 2016-04-13 Genentech, Inc. Binding polypeptides with diversified and consensus vh/vl hypervariable sequences
US20070237764A1 (en) * 2005-12-02 2007-10-11 Genentech, Inc. Binding polypeptides with restricted diversity sequences
CN103261223B (zh) 2010-10-13 2017-03-29 詹森生物科技公司 人制瘤素m抗体及使用方法
US20140079722A1 (en) * 2011-03-09 2014-03-20 Centrose, Llc Extracellular targeted drug conjugates
RU2493165C1 (ru) * 2012-02-28 2013-09-20 Общество с ограниченной ответственностью "Технофарма" Наноантитело, специфически связывающее белок muc1, способ детекции белка muc1 с помощью наноантител
EP2844262B1 (en) 2012-04-30 2018-01-10 Biothera, Inc. Beta-glucan immunotherapeutic preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
CA1339204C (en) * 1987-01-07 1997-08-05 Joyce Taylor-Papadimitriou Mucin core polypeptide, antibodies and probes
DE3856559T2 (de) * 1987-05-21 2004-04-29 Micromet Ag Multifunktionelle Proteine mit vorbestimmter Zielsetzung
JPH03503120A (ja) * 1988-02-08 1991-07-18 ジョン　ミュア　キャンサー　アンド　エージング　インスティチュート　ディビジョン　オブ　ジョン　ミュア　メモリアル　ホスピタル ヒトのガン細胞における新規なムチン様糖蛋白質表面抗原に特異的なモノクローナル抗体
EP0442926A1 (en) * 1988-11-10 1991-08-28 Imperial Cancer Research Technology Limited Polypeptides
JPH02273195A (ja) 1988-11-17 1990-11-07 Univ Melbourne ヒト多型性上皮ムチンと反応するモノクローナル抗体
US5075219A (en) * 1989-04-05 1991-12-24 John Muir Cancer & Aging Institute Monoclonal antibody which recognizes a specific glycoprotein of a human milk-fat globule membrane mucin antigen and said mucin antigen
HUT64600A (en) * 1989-11-17 1994-01-28 Unilever Nv Method for producing specific binding materials

Also Published As

Publication number Publication date
CA2090961A1 (en) 1992-03-08
FI113873B (fi) 2004-06-30
EP0483961B1 (en) 2003-02-26
DE69133200D1 (de) 2003-04-03
NO20014822L (no) 1993-05-05
GB9019553D0 (en) 1990-10-24
NO314595B1 (no) 2003-04-14
NO20014822D0 (no) 2001-10-04
NO315239B1 (no) 2003-08-04
UA46691C2 (uk) 2002-06-17
ES2193129T3 (es) 2003-11-01
AU8495391A (en) 1992-03-30
FI930984A (fi) 1993-03-05
US6204366B1 (en) 2001-03-20
EP0483961A1 (en) 1992-05-06
NO930825D0 (no) 1993-03-05
ATE233279T1 (de) 2003-03-15
RO113432B1 (ro) 1998-07-30
BG60716B1 (en) 1996-01-31
JP2003061689A (ja) 2003-03-04
US20020086978A1 (en) 2002-07-04
CA2090961C (en) 2004-01-20
HU9300609D0 (en) 1993-05-28
FI930984A0 (fi) 1993-03-05
KR930702526A (ko) 1993-09-09
JPH06500468A (ja) 1994-01-20
FI114611B (fi) 2004-11-30
JP3514456B2 (ja) 2004-03-31
WO1992004380A1 (en) 1992-03-19
HUT67796A (en) 1995-04-28
DE69133200T2 (de) 2003-11-20
BG97607A (bg) 1994-03-31
AU653167B2 (en) 1994-09-22
NO930825L (no) 1993-05-05

Similar Documents

Publication Publication Date Title
ES2193129T3 (es) Ligantes especificos.
PT99934A (pt) Processo para a producao de um anticorpo anti-htnf alfa recombinante ou humanizado
FI840219A0 (fi) Human-humanhybridom foer neoplasmer
ATE130029T1 (de) Hybridome, die monoklonale antikörper gegen neue mucin-epitope produzieren.
ATE85652T1 (de) Monoklonale antikoerper gegen humanen brustkrebs, korrespondierende hybridome, deren herstellung und verwendung.
PE20020972A1 (es) Anticuerpos recombinantes asociados a gangliosidos
FI922220A (fi) Specifika bindemedel.
NO174110C (no) Monoklonalt antistoff til anvendelse in vitro for diagnose av maligne tumor- eller akutte inflammasjonssykdommer, og som er spesifikt for N-acetyl-neuraminsyre i hybridom som produserer antistoffet
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
RU93058456A (ru) Антитела, способы диагностики, способ лечения, фармацевтическая композиция, клеточные линии
ATE84069T1 (de) Murin-hybridoma lym-2 und diagnostikantikoerper, der dadurch hergestellt ist.
FR2697088B1 (fr) Anticorps monoclonaux pour le diagnostic différentiel de cancers épithéliaux dans des épanchements séreux, hybridomes les secrétant et kit de diagnostic.
DK1414859T5 (da) Monoklonale anti-SSRP-1-antistoffer og hybridomer som producerer antistofferne
MX9605330A (es) Metodos y composiciones para el tratamiento de glomerulonefritis y otras enfermedades inflamatorias.
EA199900902A1 (ru) Моноклональное антитело, распознающее в злокачественных опухолях олигосахарид n-гликолилированная галактоза-глюкоза сиаловая кислота, и композиция, которая его содержит
DK182188A (da) Humant tumorassocieret antigen